These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 14127208

  • 1. [DRUGS AND ELECTROSHOCK].
    HEYMANS C, DESCHAEPDRYVER AF, DELAUNOIS AL, PIETTE Y.
    Riforma Med; 1964 Jan 04; 78():1-6. PubMed ID: 14127208
    [No Abstract] [Full Text] [Related]

  • 2. IMIPRAMINE AND ELECTROSHOCK THRESHOLD.
    PIETTE Y, DELAUNOIS AL, DESCHAEPDRYVER AF, HEYMANS C.
    Arch Int Pharmacodyn Ther; 1963 Jul 01; 144():293-7. PubMed ID: 14047156
    [No Abstract] [Full Text] [Related]

  • 3. [PHARMACOLOGY OF ELECTROSHOCK].
    HEYMANS C, DE SCHAEPDRYVER AF, DELAUNOIS AL, PIETTE Y.
    Med Monatsschr; 1964 May 01; 18():220-5. PubMed ID: 14230149
    [No Abstract] [Full Text] [Related]

  • 4. A SIMPLE SCREENING PROCEDURE FOR IMIPRAMINE-LIKE ANTIDEPRESSANT AGENTS.
    ASKEW BM.
    Life Sci (1962); 1963 Oct 01; 10():725-30. PubMed ID: 14077412
    [No Abstract] [Full Text] [Related]

  • 5. ANTAGONISM OF THE BLOCKING ACTION OF BRETYLIUM AND GUANETHIDINE ON THE PRESSOR EFFECT OF PHYSOSTIGMINE IN THE RAT.
    GOKHALE SD, GULATI OD, JOSHI NY.
    Br J Pharmacol Chemother; 1965 Jun 01; 24(3):624-31. PubMed ID: 14340916
    [No Abstract] [Full Text] [Related]

  • 6. Brain amines and electroshock convulsive threshold.
    Heymans C, De Schaepdryver AF, Delaunois AL, Piette Y.
    Indian J Physiol Pharmacol; 1964 Jul 01; 8(3):113-6. PubMed ID: 4378575
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4-DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE BRAIN.
    LAVERTY R, SHARMAN DF.
    Br J Pharmacol Chemother; 1965 Jun 01; 24(3):759-72. PubMed ID: 14340930
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. COMPARISON OF SOME PHARMACOLOGIC EFFECTS OF CERTAIN 6-SUBSTITUTED DOPAMINE DERIVATIVES WITH RESERPINE, GUANETHIDINE AND METARAMINOL.
    STONE CA, STAVORSKI JM, LUDDEN CT, WENGER HC, ROSS CA, TOTARO JA, PORTER CC.
    J Pharmacol Exp Ther; 1963 Nov 01; 142():147-56. PubMed ID: 14079651
    [No Abstract] [Full Text] [Related]

  • 15. [Prevention of the complications caused by the combination of reserpine and electroshock].
    PIETTE Y, DE SCHAEPDRYVER AF.
    Acta Neurol Psychiatr Belg; 1961 Apr 01; 61():355-66. PubMed ID: 13735638
    [No Abstract] [Full Text] [Related]

  • 16. Brain amines and electroshock threshold.
    DE SCHAEPDRYVER AF, PIETTE Y, DELAUNOIS AL.
    Arch Int Pharmacodyn Ther; 1962 Dec 01; 140():358-67. PubMed ID: 14026056
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. FUNCTION OF N-ACETYL ASPARTIC ACID IN THE BRAIN: EFFECTS OF CERTAIN DRUGS.
    MCINTOSH JC, COOPER JR.
    Nature; 1964 Aug 08; 203():658. PubMed ID: 14250993
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. EFFECT OF RESERPINE ON THE METABOLIC CENTRES.
    PFEIFER AK, VIZI ES, SATORY E, GALAMBOS E.
    Arch Int Pharmacodyn Ther; 1964 May 01; 149():126-35. PubMed ID: 14169876
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.